Get a glimpse into our company and investor data—powered by the PitchBook Platform
GrantLATEST DEAL TYPE
$100KLATEST DEAL AMOUNT
Developer of a biotechnology platform. The company's software provides access to user-defined diversity, affecting the success rate of biopharmaceutical and enzyme optimization, protein variant discovery and mutational mapping.